These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 17649069)

  • 1. Moose Sickness In Nova Scotia. II.
    Benson DA
    Can J Comp Med Vet Sci; 1958 Aug; 22(8):282-6. PubMed ID: 17649069
    [No Abstract]   [Full Text] [Related]  

  • 2. Nova Scotia moose mystery--a moose sickness related to cobalt- and vitamin B12 deficiency.
    Frank A; McPartlin J; Danielsson R
    Sci Total Environ; 2004 Jan; 318(1-3):89-100. PubMed ID: 14654277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moose "Sickness" In Nova Scotia-I.
    Benson DA
    Can J Comp Med Vet Sci; 1958 Jul; 22(7):244-8. PubMed ID: 17649063
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of antibody to Toxoplasma gondii in the moose (Alces alces americana Clinton) of Nova Scotia, Canada.
    Siepierski SJ; Tanner CE; Embil JA
    J Parasitol; 1990 Feb; 76(1):136-8. PubMed ID: 2299521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing wound care outcomes.
    McIsaac C
    Ostomy Wound Manage; 2005 Apr; 51(4):54-6, 58, 59 passim. PubMed ID: 16089060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in incidence and mortality from acute myocardial infarction in Nova Scotia and Saskatchewan 1974 to 1985. The Nova Scotia-Saskatchewan Cardiovascular Disease Epidemiology Group.
    Can J Cardiol; 1992 Apr; 8(3):253-8. PubMed ID: 1576559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the use of the statin antilipemic drugs: comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia.
    Cooke C; Nissen L; Sketris I; Tett SE
    Clin Ther; 2005 Apr; 27(4):497-508. PubMed ID: 15922822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
    Pilote L; Beck CA; Karp I; Alter D; Austin P; Cox J; Humphries K; Jackevicius C; Richard H; Tu JV;
    Can J Cardiol; 2004 Jan; 20(1):61-7. PubMed ID: 14968144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capacity building for health promotion and chronic disease prevention--Nova Scotia's experience.
    Heath S; Farquharson J; MacLean DR; Barkhouse K; Latter C; Joffres C
    Promot Educ; 2001; Suppl 1():17-22. PubMed ID: 11677818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the incidence of bladder cancer in Nova Scotia: a twenty-year perspective.
    McLellan RA; French CG; Bell DG
    Can J Urol; 2003 Jun; 10(3):1880-4. PubMed ID: 12892574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home care: the cornerstone of health renewal in Nova Scotia.
    Jackson RA
    Leadersh Health Serv; 1995; 4(6):5-7, 14. PubMed ID: 10153047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Listeria monocytogenes from a Nova Scotia Moose.
    Archibald RM
    Can Vet J; 1960 May; 1(5):225-6. PubMed ID: 17421180
    [No Abstract]   [Full Text] [Related]  

  • 13. General surgical practice patterns in Nova Scotia: the role of the "generalist" general surgeon.
    Chiasson PM; Henshaw JD; Roy PD
    Can J Surg; 1994 Aug; 37(4):285-8. PubMed ID: 8055384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of smoking among pregnant women in Nova Scotia from 1988 to 1992.
    Dodds L
    CMAJ; 1995 Jan; 152(2):185-90. PubMed ID: 7820800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of guidelines on health care use for the management of dyslipidemia in two Canadian provinces, Alberta and Nova Scotia, from 1990 to 2001.
    Joffres MR; Kamath TV; Williams GR; Casey J; Svenson LW
    Can J Cardiol; 2004 Jun; 20(8):767-72. PubMed ID: 15229757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underuse of acetylsalicylic acid in individuals with myocardial infarction, ischemic heart disease or stroke: data from the 1995 population-based Nova Scotia Health Survey.
    Rojas-Fernandez CH; Kephart GC; Sketris IS; Kass K
    Can J Cardiol; 1999 Mar; 15(3):291-6. PubMed ID: 10202192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying opportunities to address the congestive heart failure burden: the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study.
    Howlett JG; Johnstone DE; Sketris I; O'Reilly M; Horne GS; Cox JL;
    Can J Cardiol; 2003 Mar; 19(4):439-44. PubMed ID: 12704493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year follow-up of a province-wide cohort of surgical lung cancer patients in Nova Scotia.
    Wong DR; Henteleff HJ
    Can J Surg; 2008 Aug; 51(4):257-62. PubMed ID: 18815647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An incremental cost analysis of telehealth in Nova Scotia from a societal perspective.
    Persaud DD; Jreige S; Skedgel C; Finley J; Sargeant J; Hanlon N
    J Telemed Telecare; 2005; 11(2):77-84. PubMed ID: 15829051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia Seniors' Pharmacare beneficiaries.
    Sketris IS; Kephart GC; Frail DM; Skedgel C; Allen MJ
    Pharmacotherapy; 2004 Jun; 24(6):784-91. PubMed ID: 15222669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.